Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a Real-life Study
Sponsor: Centre Hospitalier Charles Perrens, Bordeaux
Summary
This study aims to examine the dual effects of cannabis consumption on both positive and negative symptoms of schizophrenia, across laboratory and real-world contexts. By integrating ecological momentary assessment (EMA) with cognitive tasks such as reality monitoring, the research seeks to clarify how cannabis use influences symptom severity and cognitive functioning in individuals with schizophrenia. Gaining insight into these relationships may contribute to the development of more effective management strategies and ultimately improve outcomes for patients living with schizophrenia.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-06-01
Completion Date
2028-12-31
Last Updated
2026-03-16
Healthy Volunteers
No
Conditions
Interventions
Ecological Momentary Assessment (EMA) and Reality Monitoring tasks
Use of Ecological Momentary Assessment (EMA) and a mobile Reality Monitoring task